MANHARD KIMBERLY
Insider CIK 1202094 · RDEA SVP, Regulatory & Dev Ops · INBX Director · INBX Director · HRTX Executive VP, Drug Development, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| INBX Inhibrx Biosciences, Inc. | S Sale | 2026-09-15 | 2026-09-15 | 500 | $105.05 | $52.5K | 7,500 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | S Sale | 2026-09-15 | 2026-09-15 | 500 | $105.05 | $52.5K | 7,500 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | S Sale | 2026-09-14 | 2026-09-15 | 500 | $110.26 | $55.1K | 8,000 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | S Sale | 2026-09-14 | 2026-09-15 | 500 | $110.26 | $55.1K | 8,000 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | S Sale | 2026-09-11 | 2026-09-15 | 500 | $111.78 | $55.9K | 8,500 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | S Sale | 2026-09-11 | 2026-09-15 | 500 | $111.78 | $55.9K | 8,500 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | S Sale | 2026-09-09 | 2026-09-10 | 500 | $115.80 | $57.9K | 9,000 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | S Sale | 2026-09-09 | 2026-09-10 | 500 | $115.80 | $57.9K | 9,000 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | S Sale | 2026-09-08 | 2026-09-10 | 500 | $115.14 | $57.6K | 9,500 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | S Sale | 2026-09-08 | 2026-09-10 | 500 | $115.14 | $57.6K | 9,500 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | A Award deriv | 2026-06-03 | 2026-09-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | A Award deriv | 2026-06-03 | 2026-06-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | A Award deriv | 2026-06-03 | 2026-09-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | A Award deriv | 2025-05-28 | 2025-05-29 | 15,000 | — | $0 | 15,000 | SEC↗ |
| INBX Inhibrx Biosciences, Inc. | P Buy | 2024-08-28 | 2024-08-30 | 10,000 | $13.98 | $139.8K | 10,000 | SEC↗ |
| INXB Inhibrx Biosciences, Inc. | A Award deriv | 2024-05-30 | 2024-05-30 | 30,000 | — | $0 | 30,000 | SEC↗ |
| INBX Inhibrx, Inc. | D To issuer deriv | 2024-05-30 | 2024-05-30 | 3,500 | — | $0 | 0 | SEC↗ |
| INBX Inhibrx, Inc. | D To issuer deriv | 2024-05-30 | 2024-05-30 | 17,259 | — | $0 | 0 | SEC↗ |
| INBX Inhibrx, Inc. | D To issuer deriv | 2024-05-30 | 2024-05-30 | 15,000 | — | $0 | 0 | SEC↗ |
| INBX Inhibrx, Inc. | D To issuer deriv | 2024-05-30 | 2024-05-30 | 15,000 | — | $0 | 0 | SEC↗ |
| INBX Inhibrx, Inc. | D To issuer deriv | 2024-05-30 | 2024-05-30 | 15,000 | — | $0 | 0 | SEC↗ |
| INBX Inhibrx, Inc. | A Award deriv | 2023-05-25 | 2023-05-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2023-04-13 | 2023-04-17 | 1,250 | — | $0 | 7,500 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2023-04-13 | 2023-04-17 | 4,564 | — | $0 | 27,936 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2023-04-13 | 2023-04-17 | 4,564 | — | $0 | 29,747 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | F Tax w/h | 2023-04-13 | 2023-04-17 | 1,417 | $2.88 | $4.1K | 28,330 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2023-04-13 | 2023-04-17 | 1,250 | — | $0 | 25,183 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2023-01-18 | 2023-01-20 | 149,365 | — | $0 | 149,365 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2023-01-13 | 2023-01-17 | 4,564 | — | $0 | 32,500 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2023-01-13 | 2023-01-17 | 1,250 | — | $0 | 8,750 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2023-01-13 | 2023-01-17 | 4,564 | — | $0 | 25,945 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2023-01-13 | 2023-01-17 | 1,250 | — | $0 | 21,381 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | F Tax w/h | 2023-01-13 | 2023-01-17 | 2,012 | $3.17 | $6.4K | 23,933 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | J Other | 2022-10-31 | 2023-01-17 | 1,655 | $3.27 | $5.4K | 20,131 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2022-10-13 | 2022-10-17 | 4,564 | — | $0 | 37,064 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2022-10-13 | 2022-10-17 | 1,250 | — | $0 | 10,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2022-10-13 | 2022-10-17 | 4,564 | — | $0 | 20,488 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | F Tax w/h | 2022-10-13 | 2022-10-17 | 2,012 | $3.76 | $7.6K | 18,476 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2022-10-13 | 2022-10-17 | 1,250 | — | $0 | 15,924 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2022-07-25 | 2022-07-27 | 165,961 | — | $0 | 165,961 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2022-07-13 | 2022-07-15 | 4,564 | — | $0 | 41,628 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2022-07-13 | 2022-07-15 | 1,250 | — | $0 | 11,250 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2022-07-13 | 2022-07-15 | 4,564 | — | $0 | 16,686 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | F Tax w/h | 2022-07-13 | 2022-07-15 | 2,012 | $3.01 | $6.1K | 14,674 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2022-07-13 | 2022-07-15 | 1,250 | — | $0 | 12,122 | SEC↗ |
| INBX Inhibrx, Inc. | A Award deriv | 2022-05-25 | 2022-05-26 | 15,000 | — | $0 | 50,759 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | S Sale | 2022-05-03 | 2022-05-04 | 1,504 | $4.76 | $7.2K | 10,872 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | J Other | 2022-04-29 | 2022-05-04 | 1,504 | $3.84 | $5.8K | 12,376 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2022-04-13 | 2022-04-15 | 4,564 | — | $0 | 46,192 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2022-04-13 | 2022-04-15 | 1,250 | — | $0 | 12,500 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2022-04-13 | 2022-04-15 | 1,250 | — | $0 | 8,320 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | F Tax w/h | 2022-04-13 | 2022-04-15 | 2,012 | $6.07 | $12.2K | 10,872 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2022-04-13 | 2022-04-15 | 4,564 | — | $0 | 12,884 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2022-01-13 | 2022-01-14 | 1,250 | — | $0 | 13,750 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2022-01-13 | 2022-01-14 | 4,564 | — | $0 | 50,756 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2022-01-13 | 2022-01-14 | 1,250 | — | $0 | 4,518 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2022-01-13 | 2022-01-14 | 4,564 | — | $0 | 9,082 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | F Tax w/h | 2022-01-13 | 2022-01-14 | 2,012 | $8.30 | $16.7K | 7,070 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2021-10-13 | 2021-10-15 | 55,320 | — | $0 | 55,320 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2021-10-13 | 2021-10-15 | 92,200 | — | $0 | 92,200 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2021-10-13 | 2021-10-15 | 1,250 | — | $0 | 15,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | F Tax w/h | 2021-10-13 | 2021-10-15 | 433 | $10.55 | $4.6K | 3,268 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2021-10-13 | 2021-10-15 | 1,250 | — | $0 | 3,701 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2021-07-13 | 2021-07-15 | 1,250 | — | $0 | 16,250 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | F Tax w/h | 2021-07-13 | 2021-07-15 | 433 | $13.48 | $5.8K | 2,451 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2021-07-13 | 2021-07-15 | 1,250 | — | $0 | 2,884 | SEC↗ |
| INBX Inhibrx, Inc. | A Award deriv | 2021-06-07 | 2021-06-08 | 15,000 | — | $0 | 35,759 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | S Sale | 2021-05-03 | 2021-05-04 | 1,529 | $17.66 | $27.0K | 1,634 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | J Other | 2021-04-30 | 2021-05-04 | 1,529 | $13.90 | $21.3K | 3,163 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2021-04-13 | 2021-04-15 | 1,250 | — | $0 | 17,500 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | F Tax w/h | 2021-04-13 | 2021-04-15 | 433 | $16.66 | $7.2K | 1,634 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2021-04-13 | 2021-04-15 | 1,250 | — | $0 | 2,067 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2021-01-13 | 2021-01-15 | 1,250 | — | $0 | 18,750 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2021-01-13 | 2021-01-15 | 1,250 | — | $0 | 1,250 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | F Tax w/h | 2021-01-13 | 2021-01-15 | 433 | $18.16 | $7.9K | 817 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2020-12-22 | 2020-12-23 | 10,000 | — | $0 | 48,416 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | S Sale | 2020-12-22 | 2020-12-23 | 10,000 | $20.00 | $200.0K | 0 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2020-12-22 | 2020-12-23 | 10,000 | $13.00 | $130.0K | 10,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2020-10-13 | 2020-10-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2020-10-13 | 2020-10-15 | 120,000 | — | $0 | 120,000 | SEC↗ |
| INBX Inhibrx, Inc. | A Award deriv | 2020-08-21 | 2020-08-21 | 17,259 | — | $0 | 17,259 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | S Sale | 2020-05-01 | 2020-05-01 | 1,158 | $13.97 | $16.2K | 0 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | J Other | 2020-04-30 | 2020-05-01 | 1,158 | $12.12 | $14.0K | 1,158 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2019-12-19 | 2019-12-23 | 120,000 | — | $0 | 120,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2019-11-29 | 2019-12-03 | 24,000 | — | $0 | 58,416 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | S Sale | 2019-11-29 | 2019-12-03 | 24,000 | $26.00 | $624.0K | 0 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2019-11-29 | 2019-12-03 | 24,000 | $13.00 | $312.0K | 24,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | S Sale | 2019-05-01 | 2019-05-02 | 1,109 | $18.86 | $20.9K | 0 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | J Other | 2019-04-30 | 2019-05-02 | 1,109 | $18.43 | $20.4K | 1,109 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2018-12-15 | 2018-12-18 | 100,000 | — | $0 | 100,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | S Sale | 2018-11-02 | 2018-11-02 | 494 | $30.62 | $15.1K | 0 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | J Other | 2018-10-31 | 2018-11-02 | 494 | $23.60 | $11.7K | 494 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2018-10-01 | 2018-10-02 | 6,000 | — | $0 | 82,416 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | S Sale | 2018-10-01 | 2018-10-02 | 6,000 | $32.07 | $192.4K | 0 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2018-10-01 | 2018-10-02 | 6,000 | $13.00 | $78.0K | 6,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2018-07-02 | 2018-07-03 | 6,000 | — | $0 | 88,416 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | S Sale | 2018-07-02 | 2018-07-03 | 100 | $38.85 | $3.9K | 0 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2018-07-02 | 2018-07-03 | 6,000 | $13.00 | $78.0K | 6,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | S Sale | 2018-07-02 | 2018-07-03 | 5,900 | $37.51 | $221.3K | 100 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2018-03-19 | 2018-03-19 | 18,000 | — | $0 | 94,416 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2018-03-19 | 2018-03-19 | 18,000 | $13.00 | $234.0K | 18,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | S Sale | 2018-03-19 | 2018-03-19 | 18,000 | $30.00 | $540.0K | 0 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2018-01-10 | 2018-01-12 | 7,584 | — | $0 | 112,416 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2018-01-10 | 2018-01-12 | 7,584 | $13.00 | $98.6K | 7,584 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | S Sale | 2018-01-10 | 2018-01-12 | 7,584 | $20.00 | $151.7K | 0 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2017-12-18 | 2017-12-20 | 120,000 | — | $0 | 120,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2017-04-24 | 2017-04-24 | 5,250 | — | $0 | 0 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2017-04-24 | 2017-04-24 | 16,292 | — | $0 | 0 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | S Sale | 2017-04-24 | 2017-04-24 | 21,542 | $15.33 | $330.2K | 0 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2017-04-24 | 2017-04-24 | 16,292 | $9.05 | $147.4K | 21,542 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2017-04-24 | 2017-04-24 | 5,250 | $8.80 | $46.2K | 5,250 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2016-12-21 | 2016-12-23 | 120,000 | — | $0 | 120,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2016-01-28 | 2016-01-29 | 300,000 | — | $0 | 300,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2015-12-22 | 2015-12-24 | 19,000 | — | $0 | 19,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2015-06-02 | 2015-06-03 | 10,500 | — | $0 | 21,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2015-06-02 | 2015-06-03 | 10,500 | $8.80 | $92.4K | 10,500 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | S Sale | 2015-06-02 | 2015-06-03 | 10,500 | $23.58 | $247.6K | 0 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2015-06-01 | 2015-06-03 | 2,708 | — | $0 | 16,292 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2015-06-01 | 2015-06-03 | 2,708 | $9.05 | $24.5K | 2,708 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | S Sale | 2015-06-01 | 2015-06-03 | 2,708 | $21.17 | $57.3K | 0 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2014-12-12 | 2014-12-15 | 19,000 | — | $0 | 19,000 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | M Exercise deriv | 2012-06-19 | 2012-06-20 | 4,375 | — | $0 | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | M Exercise deriv | 2012-06-19 | 2012-06-20 | 2,906 | — | $0 | 9,595 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | M Exercise deriv | 2012-06-19 | 2012-06-20 | 5,548 | — | $0 | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer deriv | 2012-06-19 | 2012-06-20 | 5,000 | $28.10 | $140.5K | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer deriv | 2012-06-19 | 2012-06-20 | 25,625 | $26.05 | $667.5K | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer deriv | 2012-06-19 | 2012-06-20 | 34,452 | $16.31 | $561.9K | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer deriv | 2012-06-19 | 2012-06-20 | 49,000 | $21.32 | $1.04M | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer deriv | 2012-06-19 | 2012-06-20 | 9,595 | $17.05 | $163.6K | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer deriv | 2012-06-19 | 2012-06-20 | 4,226 | $8.34 | $35.2K | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer deriv | 2012-06-19 | 2012-06-20 | 27,499 | $17.05 | $468.9K | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer deriv | 2012-06-19 | 2012-06-20 | 35,774 | $8.34 | $298.4K | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer deriv | 2012-06-19 | 2012-06-20 | 5,279 | $13.06 | $68.9K | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer deriv | 2012-06-19 | 2012-06-20 | 34,721 | $13.06 | $453.5K | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | M Exercise | 2012-06-19 | 2012-06-20 | 2,906 | $14.95 | $43.4K | 17,481 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | M Exercise | 2012-06-19 | 2012-06-20 | 4,375 | $5.95 | $26.0K | 14,575 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | M Exercise | 2012-06-19 | 2012-06-20 | 5,548 | $15.69 | $87.0K | 23,029 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | S Sale | 2012-06-19 | 2012-06-20 | 12,829 | $31.96 | $410.0K | 10,200 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | D To issuer | 2012-06-19 | 2012-06-20 | 10,200 | $32.00 | $326.4K | 0 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | M Exercise deriv | 2012-05-29 | 2012-05-29 | 5,000 | — | $0 | 5,000 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | M Exercise | 2012-05-29 | 2012-05-29 | 5,000 | $3.90 | $19.5K | 14,970 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | S Sale | 2012-05-29 | 2012-05-29 | 5,000 | $31.89 | $159.4K | 9,970 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | M Exercise deriv | 2012-04-30 | 2012-04-30 | 5,000 | — | $0 | 10,000 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | S Sale | 2012-04-30 | 2012-04-30 | 5,000 | $31.82 | $159.1K | 9,731 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | M Exercise | 2012-04-30 | 2012-04-30 | 5,000 | $3.90 | $19.5K | 14,731 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | M Exercise deriv | 2012-03-28 | 2012-03-29 | 5,000 | — | $0 | 15,000 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | M Exercise | 2012-03-28 | 2012-03-29 | 5,000 | $3.90 | $19.5K | 14,731 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | S Sale | 2012-03-28 | 2012-03-29 | 5,000 | $22.65 | $113.3K | 9,731 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | M Exercise deriv | 2012-02-28 | 2012-02-29 | 5,000 | — | $0 | 20,000 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | S Sale | 2012-02-28 | 2012-02-29 | 5,000 | $20.99 | $104.9K | 9,731 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | M Exercise | 2012-02-28 | 2012-02-29 | 5,000 | $3.90 | $19.5K | 14,731 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | M Exercise deriv | 2012-01-30 | 2012-01-31 | 5,000 | — | $0 | 25,000 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | M Exercise | 2012-01-30 | 2012-01-31 | 5,000 | $3.90 | $19.5K | 14,731 | SEC↗ |
| RDEA Ardea Biosciences, Inc./DE | S Sale | 2012-01-30 | 2012-01-31 | 5,000 | $18.01 | $90.1K | 9,731 | SEC↗ |